Free Trial
OTCMKTS:TRUMY

Terumo Q2 2026 Earnings Results & Report

Terumo logo
$15.05 0.00 (0.00%)
As of 11/13/2026 03:55 PM Eastern

Terumo missed analyst earnings expectations but beat on revenue in its Q2 2026 results, released November 12, 2025. The company reported EPS of $0.16 versus the $0.1611 consensus estimate, while revenue of $1.86 billion topped the $1.75 billion estimate by $111.98 million.

Earnings Announcement Details

Quarter
Q2 2026
Time
Before Market Opens

Terumo EPS Results

Actual EPS
$0.16
Consensus EPS
$0.1611
Beat/Miss
Missed by -$0.0011
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 8 quarters

Terumo Revenue Results

Actual Revenue
$1.86 billion
Expected Revenue
$1.75 billion
Beat/Miss
Beat by +$111.98 million
YoY Revenue Growth
N/A

Conference Call Resources

Terumo Q2 2026 Earnings FAQ

Terumo (OTCMKTS:TRUMY) reported earnings of $0.16 per share for Q2 2026, missing the consensus estimate of $0.1611. The report was announced on Wednesday, November 12, 2025.

Terumo reported revenue of $1.86 billion for Q2 2026, against a consensus estimate of $1.75 billion.

Terumo Earnings Headlines

Terumo (OTCMKTS:TRUMY) Shares Gap Down Following Weak Earnings
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
Terumo (OTCMKTS:TRUMY) Stock Falls 7.4% Following Weak Earnings
Terumo Corporation (TRUMY) Q2 2027 Earnings Call Transcript
Terumo ADR (TRUMY) Ratios
See More Terumo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Terumo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Terumo and other key companies, straight to your email.

About Terumo

Terumo (OTCMKTS:TRUMY) Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services.

Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies.

Headquartered in Tokyo, Terumo serves healthcare customers in Japan and markets around the world. Its products support areas including patient care, cardiovascular treatment, transfusion medicine and cell therapy.

View Terumo Profile